Douglas Darr, Patrick Morand, and Reed McManigle will join the Pittsburgh Life Sciences Greenhouse, the private/public partnership announced last week. Darr, previously vice president of business and technology development at the North Carolina Biotechnology Center for more than eight years, will become vice president and chief scientific officer. He holds a bachelor’s degree in biology, a master’s in physiology, and a doctorate in physiology, from Penn State University. Morand previously was vice president for commercial operations for Genesis Therapeutics. McManigle was technology-licensing manager for the University of Pittsburgh.
Elizabeth Song has been appointed vice president of business development and Margus Annuk is the new director of clinical development at EGeen, a Foster City, Calif.,company that does association studies using DNA from the Estonian Genome Project. Song was director of business development at Lynx Therapeutics. Previously, Song was director of viral research at Virologix, and senior scientist at Chiron. Annuk was an associate professor and head of surgical anatomy at Tartu University in Estonia, where he received his MD degree.
Joseph Smith has been appointed vice president and general counsel, and Russel Enns has been named vice president of regulatory and clinical affairs at Sunnyvale, Calif.-based Cepheid, the company announced. Smith was most recently vice president, business development, at the Applied Biosystems Group of Applera. Enns previously was a regulatory consultant.
Ian Howes was appointed CFO and senior vice president of finance and administration at Durham, NC-based Serenex, and Anil Goyal was named vice president of business development. Howes was CFO at Research Triangle Park, NC-based Paradigm Genetics, while Goyal was senior manager of corporate development for Millennium Pharmaceuticals.